ABL1 and mixed phenotype acute leukemia: The former includes cases with BCR::ABL1 and KMT2A rearrangements (both also previously recognized by WHO-HAEM4R) and two new entities: MPAL with ZNF384 rearrangement and ALAL/MPAL with BCL11 rearrangement/activation.